We’re so glad you found us! This search is complete, but if you're looking for a new role, we encourage you to take a look at our openings page.


CHIEF DEVELOPMENT OFFICER
QUANTUM LEAP HEALTHCARE COLLABORATIVE

 
 

Click on the link below for the full opportunity description:

THIS POSITION IS HYBRID AND THE SUCCESSFUL CANDIDATE MUST LIVE A COMMUTABLE DISTANCE TO THE SAN FRANCISCO OFFICE. EVERY THURSDAY IS “WORK IN PERSON” DAY FOR ALL TEAM MEMBERS OF QLHC.

POSITION OVERVIEW

Quantum Leap Healthcare Collaborative is seeking an experienced Chief Development Officer, who will be responsible for planning, executing and evaluating all fundraising and development initiatives. The CDO will establish fundraising priorities and objectives; create fundraising strategies to meet specific program goals; identify and profile current and prospective individual, business, and foundation prospects; develop and cultivate positive relationships with donors and prospects; and solicit and steward major donors.

YOU ARE A/AN:

  • Chief Development Officer with deep experience in building and executing a successful, multi-channel fundraising strategy

  • Skillful and determined fundraiser who Is gifted at building, sustaining, and growing relationships with individual donors, foundations, corporations, and other stakeholders  

  • Passionate about and highly motivated by the opportunity to deliver better, less costly healthcare to patients in need

SALARY/BENEFITS

  • Salary range is $210,000-$250,000

  • Benefits include: 

    • Hybrid Work Environment

    • Medical, Dental and Vision plans 100% employer covered

    • Short Term Disability and Long Term Disability

    • Life and AD&D Insurance – 100% employer covered with optional buy up plans

    • 401k Retirement plan with employer match

    • FSA

    • Employee Assistance Program (EAP)

    • Paid Holidays – 16 annually

    • Sick and Vacation Time 

  • The opportunity to raise crucial support for high-impact clinical research and patient-centered outcome and care to save lives

To learn more about the impact of Quantum Leap Healthcare Collaborative, please click on the links below:

Natera to Present Data from the BEATRICE and I-SPY2 Trials in Early-Stage TNBC and HR+/HER2- Breast Cancer at the 2022 AACR Annual Meeting

UCSF Deploys Innovative Data System to Integrate Research and Care

Laura Esserman in conversation with Janet Woodcock, Acting Commissioner of Food and Drug Administration at the CRAACO conference, April 27, 2021

EQUITY STATEMENT

At Quantum Leap Healthcare Collaborative, we are committed to nurturing a culture of equity and inclusion. We believe that diversity, in all its forms, enriches our organization and strengthens our mission. Our commitment to equity extends to every aspect of our work, from research and innovation to team collaboration and decision-making.

We strive to create an environment where all individuals, regardless of background, can thrive and contribute their unique perspectives. We actively promote fairness, respect, and equal opportunities for growth and development. Our dedication to equity drives us to identify and address any barriers that may hinder inclusivity within our organization.

By embracing equity, we aim to not only advance scientific innovation but also set an example for our industry.

Together, we are building a future where diversity is celebrated, equity is the principle, and our collective efforts lead to breakthroughs that positively impact society.